Today we live, Together we fight
Transcription
Today we live, Together we fight
Today we live, Together we fight Today, Together JOIN THE MOVEMENT AND SHOW YOUR SUPPORT BY HELPING US R AISE AWARENESS ABOUT CHRONIC MYELOID LEUKEMIA, A R ARE CANCER. UR LOF S I T E .COM PLEA SE IN SERT YOUR LOGO HERE Yes, it’s leukemia, it’s cancer. But if treated effectively with recommended treatments, patients with chronic myeloid leukemia (CML) today can have a life expectancy similar to that of the general population. While medicine has provided us with the weapon we need to live and enjoy a good quality of life, it is still an ongoing fight to help each patient access treatment. [Space for localization/adding local organization’s story… for example: Right here in Spain, there are XYZ patients IMAGE PLACEHOLDER who don’t want to struggle with CML. And we are fighting to change that.] Join the movement for access to treatment for this rare cancer today and together with all of us and help raise awareness on VENUE WHERE Name of venue Lorem Ipsum Road, 161 XXXX, City Name Country Alis sequias dendes simi, nes sunt eosedi blam, consequo consequibus. www.urleventname.com twitter.com/eventname facebook.com/eventname Chronic myeloid leukemia (CML) CML is a rare cancer that is characterized by an unregulated growth of white blood cells in the bone marrow and the accumulation of these cells in the blood. Even though there has been a medical revolution in treating CML over the past decade, not every patient has access to the best available treatment and care. Those who have access struggle to live with CML as a chronic, life-long disease. Without treatment life expectancy is three years. Contact Name +3 4 9 15 6 318 0 1 World CML Day Initiated by the patient community in 2008, September 22 (9/22) has marked World CML Day because of its symbolic significance – the disease is caused by the change of chromosomes 9 and 22. On this day, patients across the globe come together to raise awareness about their needs to the general public, politicians, and medical professionals across the world. The CML Advocates Network The CML Advocates Network is a global non-profit community run by patients in roughly 80 countries. Launched in 2007 by four founding organizations, it now consists of more than 100 patient groups, offering support by sharing best practices, information, and advice for CML patient advocates. Find out more at http://cmladvocates.net
Similar documents
Clonal haematopoeitic disorders Proliferation of one of myeloid lineages Relatively normal maturation
More information
Clonal haematopoeitic disorders Proliferation of one of myeloid lineages Relatively normal maturation
More information
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Size, Causes, Outlook, Overview and Pipeline Review, H1 2016
Global Markets Direct's, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/chronic-myelocytic-leukemia-cml-chronic-myeloid-leukemia-pipeline-review-h1-2016
More information